Snowden Capital Advisors LLC lifted its position in Cameco Co. (NYSE:CCJ - Free Report) TSE: CCO by 125.6% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 16,697 shares of the basic materials company's stock after buying an additional 9,295 shares during the period. Snowden Capital Advisors LLC's holdings in Cameco were worth $858,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Shell Asset Management Co. acquired a new stake in shares of Cameco during the 4th quarter valued at $185,000. Recurrent Investment Advisors LLC acquired a new stake in Cameco during the 4th quarter worth about $347,000. Polar Asset Management Partners Inc. grew its stake in Cameco by 337.2% during the 4th quarter. Polar Asset Management Partners Inc. now owns 98,376 shares of the basic materials company's stock valued at $4,742,000 after acquiring an additional 75,876 shares in the last quarter. Quantinno Capital Management LP increased its holdings in shares of Cameco by 4.3% in the 4th quarter. Quantinno Capital Management LP now owns 82,483 shares of the basic materials company's stock valued at $4,239,000 after purchasing an additional 3,371 shares during the period. Finally, Northeast Financial Consultants Inc acquired a new stake in shares of Cameco during the fourth quarter worth approximately $232,000. 70.21% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
CCJ has been the subject of a number of research analyst reports. Sanford C. Bernstein began coverage on shares of Cameco in a research report on Tuesday, April 1st. They issued an "outperform" rating and a $52.00 target price for the company. Glj Research lifted their price objective on Cameco from $62.76 to $75.68 and gave the company a "buy" rating in a research report on Wednesday, March 12th. Royal Bank of Canada restated an "outperform" rating and issued a $90.00 target price on shares of Cameco in a research note on Tuesday, March 4th. Desjardins initiated coverage on Cameco in a research note on Friday, April 4th. They set a "buy" rating for the company. Finally, Scotiabank reissued an "outperform" rating on shares of Cameco in a research note on Wednesday, May 14th. One equities research analyst has rated the stock with a hold rating, nine have given a buy rating and three have given a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Buy" and a consensus price target of $70.03.
Read Our Latest Analysis on CCJ
Cameco Stock Performance
CCJ opened at $51.16 on Tuesday. The stock has a 50-day moving average of $43.90 and a 200-day moving average of $48.81. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.26 and a current ratio of 2.88. Cameco Co. has a 52-week low of $35.00 and a 52-week high of $62.55. The company has a market cap of $22.27 billion, a PE ratio of 182.71 and a beta of 0.89.
Cameco (NYSE:CCJ - Get Free Report) TSE: CCO last announced its quarterly earnings results on Thursday, May 1st. The basic materials company reported $0.11 EPS for the quarter, missing the consensus estimate of $0.18 by ($0.07). Cameco had a net margin of 5.39% and a return on equity of 4.34%. The company had revenue of $549.58 million for the quarter, compared to analyst estimates of $890.07 million. During the same quarter last year, the business earned $0.13 EPS. The company's revenue for the quarter was up 24.4% on a year-over-year basis. As a group, equities research analysts forecast that Cameco Co. will post 1.27 earnings per share for the current fiscal year.
About Cameco
(
Free Report)
Cameco Corporation provides uranium for the generation of electricity. It operates through Uranium, Fuel Services, Westinghouse segments. The Uranium segment is involved in the exploration for, mining, and milling, purchase, and sale of uranium concentrate. The Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate, as well as the purchase and sale of conversion services.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cameco, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cameco wasn't on the list.
While Cameco currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
